Taylor Wealth Management Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$8.24M Sell
17,082
-1,207
-7% -$597K 4.68% 5
2022
Q1
$8.98M Sell
18,289
-3,026
-14% -$1.38M 3.64% 6
2021
Q4
$9.88M Buy
21,315
+387
+2% +$163K 3.48% 7
2021
Q3
$7.8M Buy
20,928
+338
+2% +$128K 2.78% 10
2021
Q2
$7.86M Sell
20,590
-283
-1% -$108K 2.77% 11
2021
Q1
$7.49M Buy
+20,873
New +$6.71M 2.73% 11

Other funds holding ELV

Taylor Wealth Management Partners's ELV Position: Q2 2022 in Review

Taylor Wealth Management Partners reduced its Elevance Health (ELV) stake by 6.6% in Q2 2022, selling an estimated $597K and leaving 17,082 shares worth $8.24M. The position accounts for 4.68% of the portfolio, ranked #5.

Taylor Wealth Management Partners first reported a position in ELV in Q1 2021 and has held it in 6 quarters since. The position peaked at $9.88M in Q4 2021. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Taylor Wealth Management Partners held 17,082 shares of Elevance Health worth $8.24M as of Q2 2022.
  • Taylor Wealth Management Partners sold 1,207 Elevance Health shares in Q2 2022, an estimated $597K.
  • Elevance Health made up 4.68% of Taylor Wealth Management Partners's portfolio in Q2 2022, its #5 holding.
  • Taylor Wealth Management Partners first reported a position in Elevance Health in Q1 2021 and has held it in 6 quarters since.
  • Taylor Wealth Management Partners's Elevance Health position peaked at $9.88M in Q4 2021.
  • 1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.